Search JTA's historical archive dating back to 1923

News Brief

January 31, 2002
See Original Daily Bulletin From This Date

Israel-based Teva pharmaceuticals received U.S. approval to market a generic version of the anti-depressant Prozac. Teva shares rose more than 1 percent on the Tel Aviv Stock Exchange following the company’s announcement.

Recommended from JTA